Human CD134 Protein, Fc Tag
- 
									
产品编号
KMP2364
 - 
									
别名
肿瘤坏死因子受体超家族成员4, Tumor necrosis factor receptor superfamily member 4, CD134
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2364 | 
| Alias | 肿瘤坏死因子受体超家族成员4, Tumor necrosis factor receptor superfamily member 4, CD134 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD134 Protein(KMP2364) is produced in HEK293 Cells and the target gene encoding Leu29-Ala216 is expressed with a Fc tag at the C-terminus. | 
| Molecular Name | CD134 | 
| Product Introduction | CD134(OX40):TNF受体超家族成员,主要表达于活化T细胞,通过配体结合增强T细胞活化和增殖。 | 
| Molecular Weight | 20.16 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | A0A024R937 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | PBS, pH7.4 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | OX40,also termed CD134 and TNFRSF4, is a T cell co-stimulatory molecule of the TNF receptor superfamily which plays a key role in the survival and homeostasis of effector and memory T cells. OX40 is expressed on CD4+ and CD8+ T cells upon engagement of the TCR by antigen presenting cells along with co-stimulation by CD40-CD40 Ligand and CD28-B7. The interaction between OX40 and OX40 ligand(OX40L) will occur when activated T cells bind to professional antigen-presenting cells(APCs). The T-cell functions, including cytokine production, expansion, and survival, are then enhanced by the OX40 costimulatory signals. OX40 signals are critical for controlling the function and differentiation of Foxp3+ regulatory T cells. OX40-OX40L interaction regulates T-cell tolerance, peripheral T-cell homeostasis, and T-cell-mediated inflammatory diseases. | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
低速离心:12,000 rpm, 5分钟,去除不溶物。缓冲液置换:使用超滤离心管(如10 kDa截留分子量)浓缩。
可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。
							
							
							
							
						
								0